American Heart Journal
Volume 143, Issue 6 , Pages 952-960, June 2002

The SYNERGY trial: Study design and rationale☆☆★★

  • The SYNERGY Executive Committee

SYNERGY Executive Committee on behalf of the SYNERGY Trial Investigators. Durham, NC

Received 4 September 2001; accepted 5 December 2001.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Supported by AVENTIS Pharmaceutical Products, Inc, Bridgewater, NJ.

☆☆ Guest Editor for this manuscript was David A. Vorchheimer, MD, Mount Sinai Medical Center, New York, NY.

 Reprint requests: Kenneth W. Mahaffey, MD, Assistant Professor of Medicine, PO Box 17969, Duke Clinical Research Institute, Durham, NC 27715.

★★ E-mail: mahaf002@mc.duke.edu

PII: S0002-8703(02)00007-8

doi:10.1067/mhj.2002.122120

American Heart Journal
Volume 143, Issue 6 , Pages 952-960, June 2002